Myrexis, Inc. (formerly Myriad Pharmaceuticals, Inc.) is a biotechnology company focused on discovering, developing, and commercializing novel therapies for the treatment of cancer. Our pipeline includes clinical and pre-clinical product candidates with distinct mechanisms of action and novel chemical structures that have the potential to be first-in-class and/or best-in-class therapeutics.
View Top Employees from Myrexis, Inc.Website | http://myrexis.com |
Ticker | MYRX |
Revenue | $750000 |
Employees | 36 (30 on RocketReach) |
Founded | 1999 |
Address | 305 Chipeta Way, Salt Lake City, Utah 84108, US |
Phone | (801) 214-7800 |
Fax | (801) 584-3741 |
Technologies |
JavaScript,
HTML,
Twitter
+6 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Business Services General, Biotechnology, Pharmaceuticals, Oncology, Business Services, Science and Engineering, Clinical Development, Pharmaceutical, Discovery, Health Care |
Competitors | AtheroGenics , Inc., MediciNova, Inc., NeurOp, Inc., Presidio Pharmaceuticals, Inc., Progenesis |
SIC | SIC Code 679 Companies, SIC Code 67 Companies |
NAICS | NAICS Code 52 Companies, NAICS Code 523 Companies, NAICS Code 5239 Companies |
Looking for a particular Myrexis, Inc. employee's phone or email?
The Myrexis, Inc. annual revenue was $750000 in 2024.
30 people are employed at Myrexis, Inc..
Myrexis, Inc. is based in Salt Lake City, Utah.
The NAICS codes for Myrexis, Inc. are [52, 523, 5239].
The SIC codes for Myrexis, Inc. are [679, 67].